Hollis Gregory J, Keene Toby M, Ardlie Rory M, Caldicott David Ge, Stapleton Stuart G
Emergency Department and Capital Region Retrieval Service, Canberra Hospital, Canberra, Australian Capital Territory, Australia.
Quality, Safety and Risk Management, ACT Ambulance Service, Canberra, Australian Capital Territory, Australia.
Emerg Med Australas. 2017 Feb;29(1):89-95. doi: 10.1111/1742-6723.12685. Epub 2016 Oct 3.
The aim of this study was to describe prehospital use of ketamine by ACT Ambulance Service, and frequency of endotracheal intubation.
This was a retrospective study of patients receiving prehospital ketamine between 1 January and 31 December 2013. Episodes were identified from the prehospital electronic patient care records, then linkage to ED records at two receiving hospitals. Demographics, dose, indication and occasions of intubation were analysed.
A total of 163 episodes were identified; 10 of these were excluded because of lack of identifying data or missing records (age 1-97 years [mean: 43, standard deviation: 21.7], 56% men). Median total dose was 60 mg (interquartile range 70; 5-400 mg) in three doses (interquartile range 3; 1-14 mg). For patients with a weight recorded (63%), median dose was 0.73 mg/kg. Indications were analgesia 68%, agitation/combative 25%, rapid sequence intubation 5% and others 2%. A total of 26 patients were endotracheally intubated, 11 prehospital (seven as an intended rapid sequence intubation and four combative patients with return of spontaneous circulation) and 15 in the ED. Of ED intubations, 10 were trauma patients and five were drug ingestion related. Patients receiving ketamine for combativeness were more likely to be intubated than those receiving it for analgesia (25 vs 7.2%; odds ratio: 3.46; 95% confidence interval: 1.12, 10.71). In those with a weight recorded, the mg/kg dose was not associated with subsequent intubation.
Median dose for analgesia was comparable with other studies; dose for sedation was less than reported elsewhere. Intubation rate for patients receiving prehospital ketamine was 17%. Further study is recommended to assess the ED course of the non-intubated group of patients, and consideration should be given to non-weight-based methods of dose selection.
本研究旨在描述澳大利亚首都地区急救服务机构院前使用氯胺酮的情况以及气管插管的频率。
这是一项对2013年1月1日至12月31日期间接受院前氯胺酮治疗的患者的回顾性研究。通过院前电子患者护理记录识别病例,然后与两家接收医院的急诊科记录进行关联。分析了人口统计学、剂量、用药指征和插管情况。
共识别出163例病例;其中10例因缺乏识别数据或记录缺失而被排除(年龄1 - 97岁[平均:43岁,标准差:21.7岁],男性占56%)。总剂量中位数为60毫克(四分位间距70;5 - 400毫克),分三次给药(四分位间距3;1 - 14毫克)。对于有体重记录的患者(63%),剂量中位数为0.73毫克/千克。用药指征为镇痛占68%,躁动/好斗占25%,快速顺序诱导插管占5%,其他占2%。共有26例患者接受了气管插管,11例在院前(7例为预期的快速顺序诱导插管,4例为有自主循环恢复的好斗患者),15例在急诊科。在急诊科插管的患者中,10例为创伤患者,5例与药物摄入有关。因好斗接受氯胺酮治疗的患者比因镇痛接受治疗的患者更有可能接受插管(25%对7.2%;比值比:3.46;95%置信区间:1.12,10.71)。在有体重记录的患者中,毫克/千克剂量与随后的插管无关。
镇痛的剂量中位数与其他研究相当;镇静的剂量低于其他地方报道的剂量。接受院前氯胺酮治疗的患者插管率为17%。建议进一步研究评估未插管患者组在急诊科的病程,并应考虑采用非基于体重的剂量选择方法。